home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Key To Relapsing Multiple Sclerosis

  December, 6 2006 10:00
your information resource in human molecular genetics
Insights into the pathology of relapsing multiple sclerosis are provided in a study in the January 2007 issue of Nature Immunology.

This research shows that the molecule osteopontin, an inflammatory mediator, extends the lifetime of auto-aggressive immune cells and thus contributes to disease progression. Larry Steinman and colleagues studied mice lacking osteopontin, in an animal model of relapsing multiple sclerosis, which develop a less severe form of the disease. Auto-aggressive immune cells were less likely to survive in the brains of osteopontin-deficient mice compared to their normal littermates; an observation that correlated with disease remission.
In contrast, mice given osteopontin developed severe disease, ultimately leading to their death.

Using this information the authors were also able to show that osteopontin increased the lifespan of auto-aggressive immune cells grown in the lab, altering the expression of several genes that regulate cell survival and division. These findings suggest treatments targeting osteopontin might benefit multiple sclerosis patients.

Author contact:

Lawrence Steinman (Stanford University, CA, USA)
E-mail: steinman@stanford.edu

Additional contact for comment on the paper:

Joan Goverman, University of Washington, Seattle, WA, USA)
E-mail: goverman@u.washington.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.